Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000249·Janus Henderson Group Ltd.
Schedule 13G ownership disclosure
Lexeo Therapeutics Inc
Common Stock · CUSIP: 52886X107
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 3,684,383 · Class: 11.1%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 2,041,481 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000249
- Form type
- SCHEDULE 13G/A
- Filer
- Janus Henderson Group Ltd.
- CIK
- CIK 1274173
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership